Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects

NCT02230995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: metformin
DRUG: empagliflozin/metformin
DRUG: empagliflozin

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]